We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Bimatoprost 0.03% (Latisse, eyelash growth)
The one strongly-evidenced eyelash-growth treatment — a prescription prostaglandin-analog drug (Latisse 0.03%) applied to the upper lash line, not a cosmetic. Randomized vehicle-controlled trials and a meta-analysis show it reliably lengthens, thickens, and darkens lashes by prolonging the hair-growth (anagen) phase. The honest framing: it genuinely works, but it's a drug with real trade-offs — the benefit fully reverses within a few months of stopping, and it carries ocular/periorbital side effects (eye redness, eyelid and iris darkening, and hollowing of the upper eyelid from fat atrophy, which can be disfiguring and sometimes irreversible). It doesn't help all causes of lash loss (e.g. alopecia areata). Use under a clinician.
Prescription medication — not a dietary supplement
Bimatoprost (lashes) is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Bimatoprost (lashes) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2009–2026 with a typical study size of 209 participants.
Based on 38 studies · 2 meta-analyses · 33 RCTs · 1,269 total participants
Confidence
High confidenceBy outcome
Multiple double-masked, randomized, vehicle-controlled trials plus a six-RCT meta-analysis and a large pooled safety dataset show bimatoprost reliably increases eyelash length, thickness, and darkness; FDA-approved with a clear mechanism. Held below the top because it is a prescription drug whose benefit fully reverses on stopping, it carries real ocular/periorbital side effects, and it does not help all causes of lash loss.
31 rigorous studies
31 randomized trials · 0 meta-analyses · 0 systematic reviews
Our evidence rating for Bimatoprost (lashes) is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
Bimatoprost 0.03% (Latisse) is a prostaglandin-analog drug, originally a glaucoma eye drop, that is FDA-approved for eyelash hypotrichosis (inadequate lashes) and applied once daily to the upper lash line. This entry covers that topical lash use; it is a prescription medicine, not a cosmetic or supplement.
Mechanistically it stimulates prostaglandin receptors in the hair-follicle dermal papilla and melanocytes, prolonging the anagen (growth) phase and increasing melanogenesis — so lashes grow longer, thicker, and darker (an animal eyelash model confirms anagen prolongation without new follicle formation).
The efficacy evidence is strong: multiple double-masked, randomized, vehicle-controlled trials show significant benefit — a 1-year RCT (Glaser et al., 2015) met its primary endpoint in both idiopathic (40.2% vs 6.8% responders) and chemotherapy-induced hypotrichosis, and two Japanese RCTs (Harii et al., 2014; n=209) showed ~77-89% achieving ≥1-grade improvement vs 18-28% on vehicle, with objective gains in lash length, thickness, and darkness.
A systematic review/meta-analysis of six RCTs (Jiang et al., 2023) confirmed significant improvement in hair length and density, and a pooled safety analysis of six trials (Wirta et al., 2015; n=1059) characterized the side-effect profile.
The honest caveats: the effect is not durable — it is maintained only ~2 months and markedly diminishes 4-6 months after stopping, so continuous use is required; side effects include conjunctival hyperemia (eye redness), eyelid and iris pigmentation, and — with chronic use — periorbital fat atrophy causing deepening of the upper-lid sulcus, eyelid retraction, and enophthalmos (case reports note this can be disfiguring, especially with one-sided use, and not always reversible); and it does not work for all causes of lash loss (no efficacy in alopecia areata).
So the honest summary: bimatoprost is the evidence-based lash-growth treatment, but it is a prescription drug with reversible benefit and real ocular/periorbital risks that warrant clinician oversight. None of this is a cosmetic claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a prescription-drug badge and a topical-only disclaimer.
Bimatoprost stimulates prostaglandin receptors in the hair-follicle dermal papilla and melanocytes, prolonging the anagen (active growth) phase and increasing pigment production. The result is longer, thicker, darker lashes — an animal eyelash model confirms anagen prolongation without forming new follicles, so the gains depend on continued treatment.
Avoid — prostaglandin analogs are generally not advised in pregnancy; cosmetic lash enhancement is not worth the risk.
Only under ophthalmologist guidance — lash-line bimatoprost can interact with IOP management and prostaglandin therapy.
Bimatoprost did not promote lash growth in alopecia areata — it won't overcome active autoimmune follicular loss.
Adding lash-line bimatoprost on top of prostaglandin glaucoma therapy can compound effects/side effects and may affect intraocular-pressure management. Coordinate with your ophthalmologist. This is an ocular-drug concern, not an ingestible interaction.
Tip: Apply precisely to the lash line; usually mild and early. Discontinue if persistent.
Tip: Iris darkening can be permanent; eyelid darkening is usually reversible. Discontinue and consult an eye doctor if it occurs.
Tip: Can be disfiguring and not always reversible, especially with one-sided use; stop and seek specialist care if hollowing develops.
Bimatoprost (lashes) has an evidence score of 8/10 — strong evidence based on 36 indexed studies, including 2 meta-analyses. The one strongly-evidenced eyelash-growth treatment — a prescription prostaglandin-analog drug (Latisse 0.03%) applied to the upper lash line, not a cosmetic. Randomized vehicle-controlled trials and a meta-analysis show it reliably lengthens, thickens, and darkens lashes by prolonging the hair-growth (anagen) phase. The honest framing: it genuinely works, but it's a drug with real trade-offs — the benefit fully reverses within a few months of stopping, and it carries ocular/periorbital side effects (eye redness, eyelid and iris darkening, and hollowing of the upper eyelid from fat atrophy, which can be disfiguring and sometimes irreversible). It doesn't help all causes of lash loss (e.g. alopecia areata). Use under a clinician. Representative study: PMID 36999072.
The commonly studied dose of Bimatoprost (lashes) is Prescription topical. Bimatoprost 0.03% is applied once daily as a thin line to the skin of the UPPER eyelid margin at the lash base (not to the lower lid, and avoid getting it in the eye), using a fresh applicator per eye. Continuous use is needed to maintain results. Use under a clinician, especially if you have glaucoma or take prostaglandin eye drops. There is no oral or systemic use. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Bimatoprost (lashes) is in the evening. It can be taken on an empty stomach. Bimatoprost is applied once daily to the upper lash line (commonly at night, to clean skin without contact lenses); there is no meal-timing relationship.
Bimatoprost (lashes) should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are conjunctival hyperemia (eye redness) and eyelid itching, eyelid skin and iris pigmentation, periorbital fat atrophy / upper-lid-sulcus deepening (prostaglandin-associated periorbitopathy). Use caution if any of these apply to you: Apply only to the upper eyelid margin — keep out of the eye and off the lower lid; not for ingestion; Known allergy/sensitivity to bimatoprost or prostaglandin analogs; Active eye/eyelid infection or inflammation.
Adapalene
Mostly mechanism / observationalA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Benzoyl Peroxide
Mostly mechanism / observationalA frontline over-the-counter acne medicine applied to the skin — a drug, not a supplement or cosmetic. Benzoyl peroxide (BPO) kills the acne bacterium Cutibacterium (Propionibacterium) acnes by an oxidative mechanism that, crucially, does NOT drive antibiotic resistance, and it is also mildly comedolytic and anti-inflammatory. The honest framing: this is one of the best-evidenced topical acne treatments — a 120-trial Cochrane review and a 35-RCT network meta-analysis show it beats placebo and matches topical antibiotics — but it commonly causes dryness and irritation, it bleaches fabrics, towels, and hair, and BPO monotherapy is consistently outperformed by fixed combinations (adapalene-BPO, clindamycin-BPO). A genuinely effective acne drug with real, manageable downsides.
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Azelaic Acid
Mostly mechanism / observationalA topical skincare acid applied to the skin for rosacea, acne, and uneven tone — unusual among 'cosmetic' actives because it has genuine drug-grade evidence. Azelaic acid is a naturally occurring dicarboxylic acid that is anti-inflammatory, antimicrobial, and a tyrosinase inhibitor. It is sold both as an over-the-counter cosmetic (around 10%) AND as a 15-20% prescription medication. The honest framing: the strongest, best-replicated evidence — including double-blind phase III trials and a Cochrane review that rated it high-quality for papulopustular rosacea — used the PRESCRIPTION strengths (15-20%), not the ~10% OTC cosmetic form. It also has solid evidence for acne and melasma. Head-to-head it is beaten for acne (by benzoyl peroxide + clindamycin) and tends to cause more local irritation (burning, stinging) than several comparators. For rosacea or persistent acne, the prescription form under a clinician is the evidence-based route.
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 38 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.